Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Strasak, Alexander M ^a   Kim, Arthur Y ^b   Lauer, Georg M ^b   de Sousa, Paulo S ^c   Ginuino, Cleber F ^c   Fernandes, Carlos A ^d   Velloso, Carlos E ^c   de Almeida, Adilson J ^c,e   de Oliveira, Jaqueline M ^c   Yoshida, Clara F ^c   zur Wiesch, Julian S ^f   Paranhos Baccalá, Gláucia ^g   Lang, Stefan ^h   Brant, Larry J ⁱ   Ulmer, Hanno ^a   Strohmaier, Susanne ^a   Kaltenbach, Lalit ^a   Lampe, Elisabeth ^c   Lewis Ximenez, Lia L ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Hepatitis Division   (Brazil)

^e HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g Emerging Pathogens Laboratory   (France)

^h UNIVERSITY OF INNSBRUCK   (Austria)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ACUTE HEPATITIS; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; VIRAL CLEARANCE; VIREMIA; BLOOD; COHORT ANALYSIS; FOLLOW UP; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY;

ADULT; AGED; BRAZIL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; YOUNG ADULT;

EID: 78651242706     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-15     Document Type: Article

References (28)

1. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003, 125:80-88. 10.1016/S0016-5085(03)00668-1, 12851873.
2. Corey KE, Ross AS, Wurcel A, Schulze Zur Wiesch J, Kim AY, Lauer GM, Chung RT. Outcomes and treatment of acute hepatitis C virus infection in a United States population. Clin Gastroenterol Hepatol 2006, 4:1278-1282. 10.1016/j.cgh.2006.06.026, 1828916, 16931171.
3. The Global Burden of Hepatitis C Working Group Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004, 44:20-29. 10.1177/0091270003258669, 14681338, The Global Burden of Hepatitis C Working Group.
4. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008, 372:321-332. 10.1016/S0140-6736(08)61116-2, 18657711.
5. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005, 9:383-398. 10.1016/j.cld.2005.05.003, 16023972.
6. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. J Viral Hepat 2006, 13:34-41. 10.1111/j.1365-2893.2005.00651.x, 16364080.
7. Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, Gangl A, Ferenci P. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003, 37:60-64. 10.1053/jhep.2003.50019, 12500189.
8. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP, . German Acute Hepatitis C Therapy Group Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001, 345:1452-1457. 10.1056/NEJMoa011232, 11794193, German Acute Hepatitis C Therapy Group.
9. Blackard JT, Shata MT, Shire NJ, Sherman KE. Acute hepatitis C virus infection: a chronic problem. Hepatology 2008, 47:321-331. 10.1002/hep.21902, 2277496, 18161707.
10. Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR. Acute hepatitis C in a contemporary US cohort: Modes of acquisition and factors influencing viral clearance. J Infect Dis 2007, 196:1474-1482. 10.1086/522608, 18008226.
11. Sharaf Eldin N, Ismail S, Mansour H, Rekacewicz C, El-Houssinie M, El-Kafrawy S, El Aidi S, Abdel-Hamid M, Esmat G, Pol S, Fontanet A, Mohamed MK. Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a. PLoS One 2008, 3(12):e4085. 10.1371/journal.pone.0004085, 2605267, 19115010.
12. Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology 2009, 136:26-31. 10.1053/j.gastro.2008.11.049, 19059257.
13. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP, Rehermann B. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000, 6:578-582. 10.1038/75063, 10802716.
14. Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001, 33:321-327. 10.1053/jhep.2001.22112, 11172332.
15. Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, Roundtree S, Thomas DL, McKeating J, Cox A. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 2005, 41:667-675. 10.1086/432478, 16080089.
16. Chen M, Sällberg M, Sönnerborg A, Weiland O, Mattsson L, Jin L, Birkett A, Peterson D, Milich DR. Limited humoral immunity in hepatitis C virus infection. Gastroenterology 1999, 116:135-143. 10.1016/S0016-5085(99)70237-4, 9869611.
17. Heller T, Rehermann B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis 2005, 25:7-17. 10.1055/s-2005-864778, 15731994.
18. Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 2004, 101:10149-10154. 10.1073/pnas.0403519101, 454180, 15220475.
19. Nikolaeva LI, Blokhina NP, Tsurikova NN, Voronkova NV, Miminoshvili MI, Braginsky DM, Yastrebova ON, Booynitskaya OB, Isaeva OV, Michailov MI, Archakov AI. Virus-specific antibody titers in different phases of hepatitis C virus infection. J Viral Hepat 2002, 9:429-437. 10.1046/j.1365-2893.2002.00369.x, 12431205.
20. Lewis-Ximenez LL, Lauer GM, Schulze Zur Wiesch J, de Sousa PS, Ginuino CF, Paranhos-Baccalá G, Ulmer H, Pfeiffer KP, Goebel G, Pereira JL, Mendes de Oliveira J, Yoshida CF, Lampe E, Velloso CE, Alves Pinto M, Coelho HS, Almeida AJ, Fernandes CA, Kim AY, Strasak AM. Prospective Follow-Up of Patients with Acute Hepatitis C Virus Infection in Brazil. Clin Infect Dis 2010, 50:1222-1230. 10.1086/651599, 20235831.
21. Amin J, Law MG, Micallef J, Jauncey M, Van Beek I, Kaldor JM, Dore GJ. Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. Epidemiol Infect 2007, 135:144-150. 10.1017/S0950268806006388, 2870537, 16707030.
22. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005, 40:951-958. 10.1086/428578, 15824985.
23. McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, Kim AY. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis 2009, 49:1051-1060. 10.1086/605561, 2741541, 19725787.
24. Messick K, Sanders JC, Goedert JJ, Eyster ME. Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders. Haemophilia 2001, 7:568-574. 10.1046/j.1365-2516.2001.00559.x, 11851755.
25. Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?. J Viral Hepat 2004, 11:563-570. 10.1111/j.1365-2893.2004.00533.x, 15500558.
26. Lefrère JJ, Guiramand S, Lefrère F, Mariotti M, Aumont P, Lerable J, Petit JC, Girot R, Morand-Joubert L. Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 1997, 175:316-322.
27. Shata MT, Tricoche N, Perkus M, Tom D, Brotman B, McCormack P, Pfahler W, Lee DH, Tobler LH, Busch M, Prince AM. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 2003, 314:601-616. 10.1016/S0042-6822(03)00461-6, 14554088.
28. Bossi V, Galli C. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection. J Clin Virol 2004, 30:45-49. 10.1016/j.jcv.2003.08.007, 15072753.